Column Group
Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Immune Design, and represent 100.00% of Column Group's stock portfolio.
- Column Group has $39M in assets under management (AUM), dropping by -40.92%.
- Central Index Key (CIK): 0001347769
Portfolio Holdings for Column Group
Column Group holds 1 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Immune Design | 100.0 | $39M | 3.2M | 12.20 |
|
Past Filings by Column Group
SEC 13F filings are viewable for Column Group going back to 2014
- Column Group 2015 Q3 filed Nov. 6, 2015
- Column Group 2015 Q2 filed Aug. 6, 2015
- Column Group 2015 Q1 filed April 23, 2015
- Column Group 2014 Q4 filed Feb. 5, 2015